Live Breaking News & Updates on Roserm Mental Health

Stay updated with breaking news from Roserm mental health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves Otsuka and Lundbeck's ABILIFY ASIMTUFII® (aripiprazole), the First Once-Every-Two-Months Long-acting Injectable (LAI) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults | Illinois

PRINCETON, N.J. & DEERFIELD, Ill. (BUSINESS WIRE) Apr 27, 2023 ....

United States , Nordrhein Westfalen , John Kraus , Johan Luthman , Statesjeffrey Gilbert , Statesdyana Lescohier , Statesrobert Murphy , Otsuka America Pharmaceutical Inc , American Psychiatric Association , Otsuka Pharmaceutical Development Commercialization Inc , Co Ltd , Otsuka Pharmaceutical Co Ltd , Otsuka Holdings Co Ltd , Drug Administration , H Lundbeck , Otsuka Pharmaceutical Company Ltd , Psychopharmacology Institute , World Health Organization , National Institute Of Mental Health , Roserm Mental Health , National Pregnancy Registry For Atypical Antipsychotics , Corporate Communications , America Pharmaceutical , New Drug Application , Important Safety Information , National Pregnancy Registry ,